/Companies

Sanifit Therapeutics

23,089 employees on LinkedIn · 5 known investors

Find your way into Sanifit Therapeutics

Sign up to see every warm intro you have to Sanifit Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Sanifit Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

CSL is a biotechnology company that develops and manufactures plasma-derived and other therapies, including biotherapies for rare and serious diseases, vaccines, and treatments for iron deficiency and kidney disease. It operates through its CSL Behring, CSL Plasma, CSL Seqirus, and CSL Vifor businesses.

Founders & leadership

JPJoan Perello Bestard
Joan Perello BestardFounderFounder at Sanifit
CCCris Calsada
Cris CalsadaCFOformerFounder at Sanifit

Investors · 5

Funding

SEC filings, press & company announcements

$80.9M disclosed across 1 of 3 rounds · 2019

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Sanifit Therapeutics do?
CSL is a biotechnology company that develops and manufactures plasma-derived and other therapies, including biotherapies for rare and serious diseases, vaccines, and treatments for iron deficiency and kidney disease. It operates through its CSL Behring, CSL Plasma, CSL Seqirus, and CSL Vifor businesses.
Who founded Sanifit Therapeutics?
Sanifit Therapeutics was founded by Joan Perello Bestard.
Who are Sanifit Therapeutics's investors?
Sanifit Therapeutics's investors include Andera Partners, Columbus Venture Partners, Criteria Bio Ventures, Invivo Capital Partners, Ysios Capital.
How much funding has Sanifit Therapeutics raised?
Sanifit Therapeutics has disclosed $80.9M raised across 1 of its 3 known rounds.